In Vivo Growth Rates Are Poorly Correlated With Phage Therapy Success In A Mouse Infection Model

Access full-text files

Date

2012-02

Authors

Bull, J. J.
Otto, G.
Molineux, I. J.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Two classes of phages yield profoundly different levels of recovery in mice experimentally infected with an Escherichia coli O18:K1:H7 strain. Phages requiring the K1 capsule for infection (K1-dep) rescue virtually all infected mice, whereas phages not requiring the capsule (K1-ind) rescue modest numbers (similar to 30%). To rescue infected mice, K1-ind phages require at least a 10(6)-fold-higher inoculum than K1-dep phages. Yet their in vivo growth dynamics are only modestly inferior to those of K1-dep phages, and competition between the two phage types in the same mouse reveals only a slight growth advantage for the K1-dep phage. The in vivo growth rate seems unlikely to be the primary determinant of phage therapy success. An alternative explanation is that the success of K1-dep phages is due substantially to their proteomic composition. They encode an enzyme that degrades the K1 capsule, which has been shown in other work to be sufficient to cure infection in the complete absence of phages.

Description

LCSH Subject Headings

Citation

Bull, J. J., Otto, G., & Molineux, I. J. (Feb., 2012). In Vivo Growth Rates Are Poorly Correlated with Phage Therapy Success in a Mouse Infection Model. Antimicrobial Agents and Chemotherapy, 56(2), 949–954. doi:10.1128/AAC.05842-11